DHR

SELL

Danaher Corporation

Healthcare · Rank #266 · Analyzed Jul 13, 2026

$199.05

Current Price

$114.55

Intrinsic Value

-42.5%

Upside/Downside

2.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score2.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 42.5%

Fair Value Range

Low$72.93

Base (IV)$114.55

High$140.36

Entry Points

Conservative$51.05

Moderate$72.93

Aggressive$80.18

Quality & Moat Breakdown

Return on Equity7.1% → 0/1.0

Debt LevelD/E 37 → 0.5/1.0

Revenue QualityGrowth 3.9%, margin Δ-2.3% +recovery → 1.0/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins14.9% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.